Fibroblast-derived TGF-β can trigger EMT or immunosuppressive niches, whereas cytokines produced by tumor-associated macrophages (TAMs) can shield cancer cells from apoptosis or enhance invasive capabilities [164]. Here, TGFB1 is linked to neoplasm.